Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02548689 · ClinicalTrials.gov registry record
PAI-1 Expression in Non-scarring Hair Loss
A clinical trial, sponsored by Northwestern University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT02548689: Clinical Trial study, sponsored by Northwestern University.
NCT02548689 is a clinical trial that was terminated before completion, run by Northwestern University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02548689 was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects. The level of PAI-1 expression will be determined in subjects without hair loss and in subjects with non-scarring hair loss, including androgenetic alopecia, telogen effluvium and alopecia areata.
Primary Outcome
Tissue PAI-1 expression levels will be determined by immunohistochemistry, a three-layer biotin-strepavidin system. Positive PAI-1 expression per total tissue area will be quantified using the color-picker function in imaging software.The PAI-1 expression found in normal scalps will be compared to those found in scalps with hair loss.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-06 |
Why NCT02548689 stopped before completion
NCT02548689 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02548689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02548689 about?
NCT02548689 is a clinical study titled "PAI-1 Expression in Non-scarring Hair Loss". This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects. The level of PAI-1 expression will be determined in subjects without hair loss and in subjects with non-scarring hair loss, including androgenetic alopecia,...
What is the current status of trial NCT02548689?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2015-07. Estimated completion is 2021-06.
Who is sponsoring clinical trial NCT02548689?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia